The global 3D cell culture market size is estimated to reach USD 2.5 billion by 2028 from USD 1.3 billion in 2023, at a CAGR of 14.6% during the forecast period. Increased focus on development of alternatives to animal testing, rising government support and funding …
The global 3D cell culture market has experienced significant growth in recent years, driven by advancements in biotechnology, increased investment in research and development, and a growing demand for more accurate and efficient methods of drug discovery and disease modeling. Unlike traditional 2D cell cultures, …
The global 3D cell culture market is experiencing significant growth, projected to reach $2.5 billion by 2028, expanding at a compound annual growth rate (CAGR) of 14.6% from 2023 to 2028. This growth is fueled by several key drivers and opportunities within the industry. Download …
3D Cell Culture Market in terms of revenue was estimated to be worth $1.3 billion in 2023 and is poised to reach $2.5 billion by 2028, growing at a CAGR of 14.6% from 2023 to 2028 according to a new report by MarketsandMarkets™. Major factors …
What This Report Will Provide: This study involved four major activities in estimating the current size of the 3d cell culture market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was …
The growth of 3d cell culture market is driven mainly by the increasing focus on developing alternatives to animal testing, growing focus on personalized medicine, increasing incidence of chronic diseases, and the availability of funding for research. On the other hand, the lack of infrastructure …
The growth of 3d cell culture market is driven mainly by the increasing focus on developing alternatives to animal testing, growing focus on personalized medicine, increasing incidence of chronic diseases, and the availability of funding for research. On the other hand, the lack of infrastructure …
The growth of 3d cell culture market is driven mainly by the increasing focus on developing alternatives to animal testing, growing focus on personalized medicine, increasing incidence of chronic diseases, and the availability of funding for research. On the other hand, the lack of infrastructure …